Case-Case-Control Study of Patients with Carbapenem-Resistant and Third-Generation-Cephalosporin-Resistant Klebsiella pneumoniae Bloodstream Infections

A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

(2013) Luci Correa et al.   BMC INFECTIOUS DISEASES

10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

(2013) H. W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity

(2013) Mahesh Swaminathan et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The Utility of Acute Physiology and Chronic Health Evaluation II Scores for Prediction of Mortality among Intensive Care Unit (ICU) and Non-ICU Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia

(2012) Vanessa Stevens et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Population-Based Incidence of Carbapenem-Resistant Klebsiella pneumoniae along the Continuum of Care, Los Angeles County

(2012) Patricia Marquez et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Antibiotic use and the risk of carbapenem-resistant extended-spectrum- -lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study

(2011) E. I. Kritsotakis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa

(2011) Souha S. Kanj et al.   MAYO CLINIC PROCEEDINGS

Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan

(2010) Dror Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies

(2010) Efraim Bilavsky et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes

(2010) Eleni Mouloudi et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns

(2009) Khetam Hussein et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES